SCHEMBL7624965

SCHEMBL7624965

O=C(CNC(=O)OCc1ccccc1)Nc1ccc(O)cc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.67
RCOR1 Q9UKL0 1/20 0.67
MAPK1 P28482 1/20 0.56
ALDH1A1 P00352 1/20 0.55
LMNA P02545 2/20 0.54
HTT P42858 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TRPV1 Q8NER1 1/20 0.54
POLB P06746 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
KMT2A Q03164 2/20 0.52
GAA P10253 2/20 0.52
RAB9A P51151 1/20 0.52
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
MIF P14174 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7315510 0.93 KDM1A (0.67) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL7758912 0.89 KDM1A (0.64) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL11925397 0.89 KDM1A (0.64) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL9635671 0.86 POLB (0.74) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL7622075 0.85 KDM1A (0.60) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL1870929 0.85 POLB (0.71) KDM1ARCOR1ALDH1A1LMNAPOLB
SCHEMBL7758133 0.84 KDM1A (0.59) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL9780058 0.84 KDM1A (0.62) KDM1ARCOR1ALDH1A1LMNAKMT2A
SCHEMBL7761464 0.83 KMT2A (0.60) KDM1ARCOR1MAPK1ALDH1A1LMNA
SCHEMBL22338581 0.82 KDM1A (0.57) KDM1ARCOR1MAPK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020061839-A1 Serine peptidase modulators SCHARPE SIMON LODEWIJK (BE) 2002-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061839-A1 Serine peptidase modulators FAP, CTSC, DPP4 KDM1A 1959/4885RCOR1 3365/4885MAPK1 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.